• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Catalog Number 221093
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that bd bbl¿ trypticase¿ soy broth was found contaminated.No patient impact was reported.The following information was provided by the initial reporter: customer reports tsb 221093__3129898 contamination.
 
Event Description
It was reported that bd bbl¿ trypticase¿ soy broth was found contaminated.No patient impact was reported.The following information was provided by the initial reporter: customer reports tsb 221093__3129898 contamination.
 
Manufacturer Narrative
H.6 investigation summary: material 221093 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued, and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 3129898 was satisfactory per internal procedures.Formulation, filling, torqueing, and autoclaving processes were within specifications.Qc inspection and testing were satisfactory at time of release.As part of the release criteria for this product, the bhr is reviewed to confirm the following: --the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.--all autoclave parameters conformed to the validated cycle parameters for this product.--the minimum f0 for this product was met.The complaint history was reviewed, and no other complaints have been taken on this batch.Retention samples from batch 3129898 (10 tubes) were available for inspection.No signs of turbidity or contamination were observed in 10/10 retention tubes.Two uninoculated retention tubes were incubated.One tube was incubated at 33-37-degrees celsius, and one retention tube was incubated in at 20-25 degree celsius.At seven days incubation, no microbial growth was observed in 2/2 tubes.Two photos were received to assist with the investigation.The first photo shows the bottom of a tube with the media featured.The media does appear hazy in clarity with possible growth.The second photo is a micrograph labeled as wet mount with rod-shaped organisms seen.Returns also were received to assist with the investigation.Four tubes from batch 3129898 in a plastic bag were returned in a mailer envelope with paper towel padding.The tubes were not labeled or marked from usage.The media returned was hazy in 4/4 tubes.For investigation, all four returned tubes were incubated at 33-37-degrees celsius.At seven days incubation, the media clarity did not change (was not hazier) and there was no microbial growth observed.The media was gram stained and gram negative rods were observed.The haziness of the media is caused by non-viable organisms.The clarity specification for this product is clear to trace hazy.The return samples and tube in the photo has media that is more than trace hazy.Media that is outside of the appearance specification should not be used.Caution should be exercised in reporting direct microbiological stain or molecular testing directly using this medium due to the possible presence of non-viable organisms in the culture medium.Culture media sometimes contain dead organisms derived from medium constituents, which may be visible in smears of culture media or detectible by molecular testing.Product should not be used if medium shows evidence of contamination, discoloration, drying or other signs of deterioration.This complaint can be confirmed.Bd has identified a complaint trend for hazy media due to the presence of non-viables for this product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ TRYPTICASE¿ SOY BROTH
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17553715
MDR Text Key321750358
Report Number1119779-2023-00896
Device Sequence Number1
Product Code JSG
UDI-Device Identifier30382902210932
UDI-Public30382902210932
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PREAMENDMENT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number221093
Device Lot Number3129898
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2023
Initial Date FDA Received08/15/2023
Supplement Dates Manufacturer Received09/18/2023
Supplement Dates FDA Received09/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-